News

BioNTech to buy former Boston Covid vaccine rival for $1.25B
BioNTech SE is acquiring a Boston biotech that just a few years ago sued the German company for Covid-19 patent violations.
In Vitro Diagnostic Quality Control Market Research 2025: Biotechnology Boom Propels Clinical Laboratory Testing Growth, Especially in Genomics
Explore booming opportunities in the recession-proof IVD Quality Control industry with our detailed report. Discover how new technology and genomic advances drive market growth. Gain insights with ...
Cytokinetics, Incorporated (CYTK) Price Target Lowered To $53 from $71 at JPMorgan
Cytokinetics, Incorporated (NASDAQ:CYTK) is one of the 13 Biotech Stocks with Huge Upside Potential. Tessa Romero, an analyst ...
Metsera Unveils First-in-Class Once-Monthly Amylin Candidate MET-233i’s Positive Phase 1 Results
Metsera, Inc. (NASDAQ:MTSR) is one of the 13 Biotech Stocks with Huge Upside Potential. Metsera, Inc. (NASDAQ:MTSR) reported ...